110 related articles for article (PubMed ID: 25421678)
1. Detection of circulatory microRNAs in prostate cancer.
Srivastava A; Goldberger H; Afzal Z; Suy S; Collins SP; Kumar D
Methods Mol Biol; 2015; 1238():523-38. PubMed ID: 25421678
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection using a noninvasive method for quantifying miRNAs.
Rodríguez-Dorantes M; Salido-Guadarrama AI; García-Tobilla P
Methods Mol Biol; 2014; 1165():81-7. PubMed ID: 24839020
[TBL] [Abstract][Full Text] [Related]
3. miRNAs as novel biomarkers in the management of prostate cancer.
Filella X; Foj L
Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
[TBL] [Abstract][Full Text] [Related]
4. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
[TBL] [Abstract][Full Text] [Related]
5. Systemic mirnas as potential biomarkers for malignancy.
Healy NA; Heneghan HM; Miller N; Osborne CK; Schiff R; Kerin MJ
Int J Cancer; 2012 Nov; 131(10):2215-22. PubMed ID: 22618667
[TBL] [Abstract][Full Text] [Related]
6. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
Korzeniewski N; Tosev G; Pahernik S; Hadaschik B; Hohenfellner M; Duensing S
Urol Oncol; 2015 Jan; 33(1):16.e17-16.e22. PubMed ID: 25445383
[TBL] [Abstract][Full Text] [Related]
7. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
Casanova-Salas I; Rubio-Briones J; Calatrava A; Mancarella C; Masiá E; Casanova J; Fernández-Serra A; Rubio L; Ramírez-Backhaus M; Armiñán A; Domínguez-Escrig J; Martínez F; García-Casado Z; Scotlandi K; Vicent MJ; López-Guerrero JA
J Urol; 2014 Jul; 192(1):252-9. PubMed ID: 24518785
[TBL] [Abstract][Full Text] [Related]
8. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
[TBL] [Abstract][Full Text] [Related]
9. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
[TBL] [Abstract][Full Text] [Related]
10. A review of expression profiling of circulating microRNAs in men with prostate cancer.
Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA in prostate cancer: Practical aspects.
Patil PA; Magi-Galluzzi C
Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs: macro-utility as markers of prostate cancer?
Selth LA; Tilley WD; Butler LM
Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
[TBL] [Abstract][Full Text] [Related]
14. Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease.
Selth LA; Townley SL; Gillis JL; Tilley WD; Butler LM
Methods Mol Biol; 2013; 1024():235-46. PubMed ID: 23719956
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expression.
Maltby S; Plank M; Ptaschinski C; Mattes J; Foster PS
Methods Mol Biol; 2015; 1220():287-304. PubMed ID: 25388258
[TBL] [Abstract][Full Text] [Related]
16. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
Gandellini P; Folini M; Zaffaroni N
Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
[TBL] [Abstract][Full Text] [Related]
18. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma.
Sanders I; Holdenrieder S; Walgenbach-Brünagel G; von Ruecker A; Kristiansen G; Müller SC; Ellinger J
Int J Urol; 2012 Nov; 19(11):1017-25. PubMed ID: 22788411
[TBL] [Abstract][Full Text] [Related]
20. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]